ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,273Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 2588

$1.45M Total Retail Price of All Prescriptions

Rank: 24 out of 2588

765 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 765 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 765 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 25,998 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 977 923 1 2
PRAVASTATIN SODIUM 953 857 2 16
AMLODIPINE BESYLATE 873 829 3 4
WARFARIN SODIUM 845 779 4 10
METOPROLOL TARTRATE 807 748 5 9
FUROSEMIDE 782 757 6 5
SIMVASTATIN 779 717 7 1
OMEPRAZOLE 764 710 8 6
METOPROLOL SUCCINATE 752 685 9 12
LISINOPRIL 550 524 10 3
NAMENDA 508 495 11 32
DONEPEZIL HCL 507 494 12 22
CITALOPRAM HBR 489 460 13 27
POTASSIUM CHLORIDE 448 421 14 15
TRAMADOL HCL 446 435 15 19
PANTOPRAZOLE SODIUM 442 414 16 28
CLOPIDOGREL 433 391 17 30
LOSARTAN POTASSIUM 417 372 18 17
SERTRALINE HCL 413 393 19 26
HYDROCODONE-ACETAMINOPHEN 396 341 S3 20 7
PREDNISONE 349 330 21 42
ATORVASTATIN CALCIUM 293 277 22 11
CARVEDILOL 284 261 23 20
METFORMIN HCL 283 256 24 8
CEPHALEXIN 282 269 25 138
RISPERIDONE 263 237 26 57
ENALAPRIL MALEATE 257 244 27 31
HYDROCHLOROTHIAZIDE 254 240 28 13
PLAVIX 252 225 29 43
GLIMEPIRIDE 247 229 30 39
DIOVAN 247 234 30 29
ALENDRONATE SODIUM 238 214 32 21
TAMSULOSIN HCL 238 225 32 23
GABAPENTIN 234 215 34 18
TRAZODONE HCL 231 192 35 61
CLONIDINE HCL 230 198 36 54
ALLOPURINOL 192 189 37 33
CRESTOR 182 150 38 25
LOVASTATIN 173 173 39 34
CYMBALTA 172 147 40 70
CALCITONIN-SALMON 166 165 41 203
NIFEDIPINE ER 164 158 42 59
ATENOLOL 160 151 43 14
AMITRIPTYLINE HCL 160 160 R 43 91
DIGOXIN 157 149 45 38
ISOSORBIDE MONONITRATE ER 147 144 46 49
CARBIDOPA-LEVODOPA 147 147 46 83
MELOXICAM 138 131 48 51
POLYETHYLENE GLYCOL 3350 136 127 49 55
FLUTICASONE PROPIONATE 135 128 50 40
TORSEMIDE 134 100 51 133
NEXIUM 131 108 52 41
SPIRIVA 126 111 53 56
KLOR-CON 10 125 123 54 75
FENTANYL 121 117 S2 55 78
LEVEMIR FLEXPEN 116 86 56 220
FLUOXETINE HCL 114 98 57 92
ADVAIR DISKUS 108 86 58 48
GLIPIZIDE 107 106 59 44
EXELON 106 106 60 118
PROAIR HFA 106 99 60 50
PAROXETINE HCL 105 94 62 71
DIVALPROEX SODIUM 103 94 63 89
TRIAMTERENE-HCTZ 99 99 64 46
LANTUS 95 90 65 47
FORTICAL 94 94 66 293
FLOVENT HFA 90 69 67 191
METOLAZONE 89 73 68 152
RANITIDINE HCL 86 83 69 37
METFORMIN HCL ER 86 77 69 67
OXYBUTYNIN CHLORIDE 85 73 71 132
NIFEDICAL XL 84 73 72 179
KLOR-CON M10 81 68 73 139
NITROFURANTOIN MONO-MACRO 79 76 74 234
KLOR-CON M20 77 70 75 52
DIOVAN HCT 77 77 75 72
MEGESTROL ACETATE 76 76 R 77 169
HYDRALAZINE HCL 75 67 78 53
QUETIAPINE FUMARATE 73 68 79 74
TRAMADOL HCL-ACETAMINOPHEN 73 73 79 208
GLYBURIDE 72 69 R 81 65
LEVOFLOXACIN 72 61 81 77
RIVASTIGMINE 72 72 81 421
ROPINIROLE HCL 71 71 84 113
AZITHROMYCIN 71 58 84 45
ESCITALOPRAM OXALATE 70 56 86 68
ZOLPIDEM TARTRATE 70 65 86 24
OXYBUTYNIN CHLORIDE ER 70 70 86 85
VESICARE 69 67 89 172
BUSPIRONE HCL 68 64 90 173
PHENYTOIN SODIUM EXTENDED 67 62 91 109
GLIPIZIDE ER 67 50 91 73
BACLOFEN 66 48 93 142
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 53 94 35
CLOTRIMAZOLE-BETAMETHASONE 64 63 95 155
DOXAZOSIN MESYLATE 64 63 95 96
PROPRANOLOL HCL 63 63 97 128
VERAPAMIL ER 63 53 97 102
FENOFIBRATE 61 61 99 64
CEFUROXIME 61 56 99 183
LEVETIRACETAM 58 52 101 90
BENICAR 58 58 101 143
SINGULAIR 57 42 103 94
LEVEMIR 56 56 104 206
CYCLOBENZAPRINE HCL 55 44 R 105 87
NITROGLYCERIN PATCH 52 51 106 149
LYRICA 51 44 107 100
SYNTHROID 50 41 108 88
DILTIAZEM 24HR CD 50 47 108 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.